McGlone Suttner Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
McGlone Suttner Wealth Management's PFE Position: Q2 2026 in Review
McGlone Suttner Wealth Management increased its Pfizer (PFE) stake by 9.5% in Q2 2026, buying an estimated $42.6K and bringing the position to 18,823 shares worth $453K. The position accounts for 0.05% of the portfolio, ranked #137.
McGlone Suttner Wealth Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $623K in Q4 2022. 1,157 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- McGlone Suttner Wealth Management held 18,823 shares of Pfizer worth $453K as of Q2 2026.
- McGlone Suttner Wealth Management bought 1,630 Pfizer shares in Q2 2026, an estimated $42.6K.
- Pfizer made up 0.05% of McGlone Suttner Wealth Management's portfolio in Q2 2026, its #137 holding.
- McGlone Suttner Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- McGlone Suttner Wealth Management's Pfizer position peaked at $623K in Q4 2022.
- 1,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on McGlone Suttner Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.